RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EOLS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evolus Inc. stock price down 0% on Thursday
(Updated on Mar 28, 2024)

Hold candidate since Mar 27, 2024 PDF

No changes to the price of Evolus Inc. stock on the last trading day (Thursday, 28th Mar 2024). During the last trading day the stock fluctuated 3.20% from a day low at $13.92 to a day high of $14.37. The price has fallen in 5 of the last 10 days and is down by -0.5% for this period.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $13.92 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 34.73% during the next 3 months and, with a 90% probability hold a price between $18.76 and $21.84 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EOLS Signals & Forecast

The Evolus Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $13.89 and $13.96. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -6.10%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while price remained unchanged. This may be an early warning, but it may also not. We still recommend that you pay attention over the next couple of days.

Support, Risk & Stop-loss for Evolus Inc. stock

Evolus Inc. finds support from accumulated volume at $13.47 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.445 between high and low, or 3.20%. For the last week, the stock has had daily average volatility of 2.64%.

Our recommended stop-loss: $13.41 (-4.20%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 19 days ago.)

Trading Expectations (EOLS) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Evolus Inc. to open at $14.10, and during the day (based on 14 day Average True Range), to move between $13.46 and $14.54, which gives a possible trading interval of +/-$0.543 (+/-3.88%) up or down from last closing price. If Evolus Inc. takes out the full calculated possible swing range there will be an estimated 7.76% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $14.01 (0.07%) than the support at $13.47 (3.79%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Evolus Inc. stock A Buy?

Evolus Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.203 Hold/Accumulate Unchanged

Predicted Opening Price for Evolus Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$14.10 ( 0.679%) $14.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EOLS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 14.54 3.86 %
R2 14.37 2.64 %
R1 14.26 1.89 %
Current price: 14.00
Support S1 13.93 -0.536 %
S2 13.82 -1.29 %
S3 13.65 -2.50 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 14.54 3.86 %
R2 14.07 0.500 %
R1 14.01 0.0714 %
Current price 14.00
Support S1 13.47 -3.79%
S2 12.48 -10.86%
S3 11.84 -15.43%

FAQ

What is the symbol for Evolus Inc. Stock and on which exchange is it traded?
The symbol for Evolus Inc. is EOLS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Evolus Inc. Stock?
Evolus Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Evolus Inc. Stock?
Evolus Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Evolus Inc. Stock.

What's the current price of Evolus Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Evolus Inc. (EOLS) share was $14.00.

What is the 52-week high and low for Evolus Inc. Stock?
The 52-week high for Evolus Inc. Stock is $15.43 and the 52-week low is $7.08.

What is the market capitalization of Evolus Inc. Stock?
As of the 2024-03-28, the market capitalization of Evolus Inc. is 860.966M.

When is the next earnings date for Evolus Inc.?
The upcoming earnings date for Evolus Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About Evolus Inc.

Evolus. Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.... EOLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT